Employees
898
genedx was founded in 2000 by two scientists from the national institutes of health (nih) to address the needs of patients and clinicians in diagnosing rare inherited disorders. currently, genedx offers testing for more than 400 rare mendelian disorders, and gene panels for inherited cardiac disorders, inherited cancer syndromes, neurological disorders, and mitochondrial disorders. in addition, genedx also offers whole exome sequencing and whole genome chromosomal microarray testing. our highly trained and experienced physicians, geneticists, and genetic counselors work as a team to bring gene discoveries to clinical medicine for use in direct patient care. for more information, please visit our website at www.genedx.com
Loading...
Open
9.15
Mkt cap
8.5M
Volume
371K
High
9.15
P/E Ratio
-18.80
52-wk high
15.38
Low
3.59
Div yield
N/A
52-wk low
3.59
Portfolio Pulse from Avi Kapoor
December 15, 2023 | 5:46 pm
Portfolio Pulse from Avi Kapoor
December 15, 2023 | 1:17 pm
Portfolio Pulse from Benzinga Newsdesk
November 30, 2023 | 2:03 pm
Portfolio Pulse from Benzinga Newsdesk
November 22, 2023 | 9:18 pm
Portfolio Pulse from Benzinga Newsdesk
October 20, 2023 | 8:17 pm
Portfolio Pulse from Benzinga Newsdesk
September 22, 2023 | 8:18 pm
Portfolio Pulse from Happy Mohamed
August 23, 2023 | 8:29 pm
Portfolio Pulse from Happy Mohamed
July 21, 2023 | 8:19 pm
Portfolio Pulse from Happy Mohamed
July 14, 2023 | 1:36 pm
Portfolio Pulse from Bill Haddad
May 23, 2023 | 8:23 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.